• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 475083 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1416863325 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1416863325 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Boston Scientific Down 0.9% Since Credit Suisse Downgraded One Week Ago (BSX)

Published on Wed, 04/10/2013 - 09:11
By Adrienne Chilton

A week ago, Credit Suisse downgraded Boston Scientific from Outperform to Neutral. The shares closed at $7.82, or 0.9% under the $7.89 price of one week ago.

Boston Scientific (NYSE:BSX) is currently priced 1.1% above its average consensus analyst price target of $7.75. The stock should find initial support at its 50-day moving average (MA) of $7.50 and further support at its 200-day MA of $6.09.

Over the past year, Boston Scientific has traded in a range of $4.79 to $7.95 and is now at $7.84, 64% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.8% while the 200-day MA has risen 0.5%.

Boston Scientific Corporation develops, manufactures, and markets minimally invasive medical devices. The Company's products are used in interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, urology, gynecology and neuromodulation.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

Shares of Weyerhaeuser Rise Above Previo...

Shares of Weyerhaeuser (NYSE:WY) traded at a new 52-week high today of $34.76. Approxi ...

Watch for Continued Gains in Shares of V...

Shares of VCA Antech (NASDAQ:WOOF) traded today at $47.00, breaking its 52-week high. ...

Recent 52-Week High Exceeded in Shares o...

Wells Fargo (NYSE:WFC) traded today at a new 52-week high of $54.36. Approximately 6.7 ...

Watch for Continued Gains in Shares of W...

Wabtec (NYSE:WAB) traded at a new 52-week high today of $91.14. So far today approxima ...

Ventas: 52-Week High Recently Eclipsed (...

Shares of Ventas (NYSE:VTR) traded today at $69.92, breaking its 52-week high. This ne ...

Recent 52-Week High Exceeded in Shares o...

Validus Holdings (NYSE:VR) traded today at a new 52-week high of $41.40. This new high ...

US Bancorp Looks to Continue to Trade Ab...

US Bancorp (NYSE:USB) traded today at a new 52-week high of $44.49. Approximately 3.2 ...

Union Pacific Looks to Continue to Trade...

Shares of Union Pacific (NYSE:UNP) traded at a new 52-week high today of $123.37. Appr ...